The frequency of BRAF mutations and their association with pathological and demographic factors is an understudied topic, with international variation.8–13 Previous epidemiology studies have been limited by small cohorts, lack of data on covariates and pooling data from various cancers.8 Improved understanding of the characteristics associated with BRAF mutations may identify risk factors to support a targeted approach to testing. Here, BRAF is linked to cancer.